Vasocon

Eye Pain, Photophobia, Iritis + 21 more

Treatment

7 Active Studies for Vasocon

What is Vasocon

Naphazoline

The Generic name of this drug

Treatment Summary

Naphazoline is a type of medication used to reduce nasal and ocular congestion. It is available in many over-the-counter eye drops and nasal preparations. Naphazoline was first developed in 1942 as a nasal solution for congestion.

AK-Con

is the brand name

Vasocon Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

AK-Con

Naphazoline

1974

43

Effectiveness

How Vasocon Affects Patients

Naphazoline is a drug that helps to reduce congestion when applied to the nose or eyes. It works by narrowing the blood vessels in these areas, thus reducing swelling and pressure.

How Vasocon works in the body

Naphazoline is a drug that shrinks blood vessels to reduce congestion. It does this by making nerve cells release a chemical called norepinephrine. Norepinephrine binds to receptors on the walls of blood vessels and causes them to get smaller. Naphazoline can also cause blood vessels to expand back to their original size after the effects wear off. When used for a long time, naphazoline can cause the body to become dependent on it, leading to rhinitis medicamentosa when it is stopped.

When to interrupt dosage

The proposed dosage of Vasocon is contingent upon the recognized condition, for instance Eye Pain, Sinusitis and tetracycline. The amount of dosage fluctuates in connection with the technique of delivery (e.g. Solution / drops or Liquid - Ophthalmic) specified in the table beneath.

Condition

Dosage

Administration

Allergic Rhinitis

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray, Spray - Nasal, Suspension / drops, Suspension / drops - Nasal, Gel - Ophthalmic, Solution / drops - Topical, Solution / drops - Nasal, Topical

Allergy to Tree Pollen

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray, Spray - Nasal, Suspension / drops, Suspension / drops - Nasal, Gel - Ophthalmic, Solution / drops - Topical, Solution / drops - Nasal, Topical

tetracycline

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray, Spray - Nasal, Suspension / drops, Suspension / drops - Nasal, Gel - Ophthalmic, Solution / drops - Topical, Solution / drops - Nasal, Topical

Dermatitis

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray, Spray - Nasal, Suspension / drops, Suspension / drops - Nasal, Gel - Ophthalmic, Solution / drops - Topical, Solution / drops - Nasal, Topical

Otitis

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray, Spray - Nasal, Suspension / drops, Suspension / drops - Nasal, Gel - Ophthalmic, Solution / drops - Topical, Solution / drops - Nasal, Topical

Allergic Conjunctivitis (AC)

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray, Spray - Nasal, Suspension / drops, Suspension / drops - Nasal, Gel - Ophthalmic, Solution / drops - Topical, Solution / drops - Nasal, Topical

Conjunctivitis

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray, Spray - Nasal, Suspension / drops, Suspension / drops - Nasal, Gel - Ophthalmic, Solution / drops - Topical, Solution / drops - Nasal, Topical

Eye Pain

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray, Spray - Nasal, Suspension / drops, Suspension / drops - Nasal, Gel - Ophthalmic, Solution / drops - Topical, Solution / drops - Nasal, Topical

Photophobia

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray, Spray - Nasal, Suspension / drops, Suspension / drops - Nasal, Gel - Ophthalmic, Solution / drops - Topical, Solution / drops - Nasal, Topical

Iritis

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray, Spray - Nasal, Suspension / drops, Suspension / drops - Nasal, Gel - Ophthalmic, Solution / drops - Topical, Solution / drops - Nasal, Topical

Dry Eye Syndromes

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray, Spray - Nasal, Suspension / drops, Suspension / drops - Nasal, Gel - Ophthalmic, Solution / drops - Topical, Solution / drops - Nasal, Topical

Dacryocystitis

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray, Spray - Nasal, Suspension / drops, Suspension / drops - Nasal, Gel - Ophthalmic, Solution / drops - Topical, Solution / drops - Nasal, Topical

Pink Eye

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray, Spray - Nasal, Suspension / drops, Suspension / drops - Nasal, Gel - Ophthalmic, Solution / drops - Topical, Solution / drops - Nasal, Topical

Sinusitis

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray, Spray - Nasal, Suspension / drops, Suspension / drops - Nasal, Gel - Ophthalmic, Solution / drops - Topical, Solution / drops - Nasal, Topical

Blepharoconjunctivitis

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray, Spray - Nasal, Suspension / drops, Suspension / drops - Nasal, Gel - Ophthalmic, Solution / drops - Topical, Solution / drops - Nasal, Topical

Eye

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray, Spray - Nasal, Suspension / drops, Suspension / drops - Nasal, Gel - Ophthalmic, Solution / drops - Topical, Solution / drops - Nasal, Topical

ocular bacterial infections

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray, Spray - Nasal, Suspension / drops, Suspension / drops - Nasal, Gel - Ophthalmic, Solution / drops - Topical, Solution / drops - Nasal, Topical

ocular vasoconstriction therapy

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray, Spray - Nasal, Suspension / drops, Suspension / drops - Nasal, Gel - Ophthalmic, Solution / drops - Topical, Solution / drops - Nasal, Topical

Conjunctivitis, Bacterial

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray, Spray - Nasal, Suspension / drops, Suspension / drops - Nasal, Gel - Ophthalmic, Solution / drops - Topical, Solution / drops - Nasal, Topical

Conjunctivitis

, 0.25 mg/mL, 0.2675 mg/mL, 0.00012 mg/mL, 0.12 mg/mL, 0.3 mg/mL, 0.1 mg/mL, 1.0 mg/mL, 0.5 mg/mL, 0.2 mg/mL, 0.00027 mL/mL, 0.01 mL/mL, 0.0125 mL/mL, 0.00015 mg/mL, 0.21 mL/mL, 0.0625 mL/mL, 0.0025 mg/mL, 0.012 %, 0.1 %, 1.0 mg, 0.051 %, 0.02675 %, 0.05 %, 0.025 %, 5.0 mg/mL, 0.03 %, 1.12 mg/mL, 0.00012 mg/mg, 0.00025 mg/mg, 0.27 mg/mL, 0.0625 mg/mL, 0.012 mg/mL, 0.01 %, 0.00376 mg/mg

, Solution / drops, Ophthalmic, Solution / drops - Ophthalmic, Solution, Solution - Ophthalmic, Liquid - Ophthalmic, Liquid, Nasal, Liquid - Nasal, Spray, Spray - Nasal, Suspension / drops, Suspension / drops - Nasal, Gel - Ophthalmic, Solution / drops - Topical, Solution / drops - Nasal, Topical

Warnings

Vasocon has one contraindication, and it should not be employed together with the conditions in the following table.

Vasocon Contraindications

Condition

Risk Level

Notes

Severe Hypersensitivity Reactions

Do Not Combine

Naphazoline may interact with Pulse Frequency

There are 20 known major drug interactions with Vasocon.

Common Vasocon Drug Interactions

Drug Name

Risk Level

Description

Iobenguane

Major

Naphazoline can cause a decrease in the absorption of Iobenguane resulting in a reduced serum concentration and potentially a decrease in efficacy.

2,5-Dimethoxy-4-ethylthioamphetamine

Minor

The risk or severity of hypertension can be increased when Naphazoline is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.

5-methoxy-N,N-dimethyltryptamine

Minor

The risk or severity of hypertension can be increased when Naphazoline is combined with 5-methoxy-N,N-dimethyltryptamine.

Abediterol

Minor

The risk or severity of hypertension can be increased when Naphazoline is combined with Abediterol.

Aceclofenac

Minor

The risk or severity of hypertension can be increased when Naphazoline is combined with Aceclofenac.

Vasocon Toxicity & Overdose Risk

High doses of naphazoline can lead to serious health issues such as coma and death, decreased body temperature, slow heart rate, and rhinitis medicamentosa. This is especially true in children under 6 years of age. It is unknown if naphazoline is safe for children under 12 and elderly patients. Women who are pregnant or breastfeeding should consider the risks and benefits before using naphazoline.

image of a doctor in a lab doing drug, clinical research

Vasocon Novel Uses: Which Conditions Have a Clinical Trial Featuring Vasocon?

57 active clinical trials are currently assessing the potential of Vasocon to ameliorate Sinusitis, Dermatitis and Allergic Rhinitis.

Condition

Clinical Trials

Trial Phases

Conjunctivitis

0 Actively Recruiting

Photophobia

3 Actively Recruiting

Not Applicable

Sinusitis

3 Actively Recruiting

Not Applicable

Eye

0 Actively Recruiting

Dry Eye Syndromes

0 Actively Recruiting

Iritis

0 Actively Recruiting

Rhinitis, Allergic

0 Actively Recruiting

Lacrimal Duct Obstruction

0 Actively Recruiting

Eye Pain

0 Actively Recruiting

Conjunctivitis, Bacterial

0 Actively Recruiting

tetracycline

0 Actively Recruiting

Blepharoconjunctivitis

0 Actively Recruiting

ocular vasoconstriction therapy

0 Actively Recruiting

Allergic Conjunctivitis (AC)

1 Actively Recruiting

Phase 2

Pink Eye

0 Actively Recruiting

Otitis

0 Actively Recruiting

Dermatitis

0 Actively Recruiting

Dacryocystitis

0 Actively Recruiting

ocular bacterial infections

0 Actively Recruiting

Lacrimation

0 Actively Recruiting

Vasocon Reviews: What are patients saying about Vasocon?

5

Patient Review

4/8/2008

Vasocon for Eye Itching

If you can't find this drug, let me know. I highly recommend it.

5

Patient Review

9/19/2007

Vasocon for Eye Itching

I can't find this medication anywhere and it's the only thing that works for me. Does anyone know where I can purchase it?

5

Patient Review

3/14/2014

Vasocon for Eye Itching

These were the best allergy eye drops I've ever used--unfortunately, I can't find them in stores anymore.

5

Patient Review

9/19/2007

Vasocon for Eye Itching

I can't seem to find this medication anywhere, and I haven't been able to find a comparable replacement. If anyone knows where I can purchase this over-the-counter medication, please let me know.

5

Patient Review

4/10/2010

Vasocon for Eye Itching

I had a lot of success with this treatment for my severe allergies. It's hard to find, but worth it!

5

Patient Review

3/14/2014

Vasocon for Eye Itching

These are the best allergy eye drops I've ever used.

5

Patient Review

4/8/2008

Vasocon for Eye Itching

I can't find this drug anymore and it was the best. Does anyone know of a similar one?

5

Patient Review

4/10/2010

Vasocon for Eye Itching

I can't find this product anywhere! It's the only thing that has worked for my severe allergies.

2

Patient Review

8/9/2009

Vasocon for Red Eyes

This treatment is good, but it could be better.

2

Patient Review

8/9/2009

Vasocon for Red Eyes

This treatment is good, but it didn't completely solve my problem.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about vasocon

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How to use eye drops?

"Tilt your head back and look up. With 1 hand, pull your lower eyelid down and away from your eyeball — this makes a “pocket” for the drops. With the other hand, hold the eye drop bottle upside down with the tip just above the pocket. Squeeze the prescribed number of eye drops into the pocket."

Answered by AI

What is Vasocon used for?

"If you have a life-threatening emergency, Vasocon Injection can help. It relaxes airways and increases blood pressure, which can help with severe allergic reactions and cardiac arrest."

Answered by AI

What is Naphazoline hydrochloride?

"This medication can be used to relieve temporary eye redness, puffiness, itching, and watering that is common with allergies. Naphazoline is a decongestant and it belongs to a class of drugs known as sympathomimetic amines. It works by narrowing the blood vessels in the eye temporarily."

Answered by AI

How often can you use Naphcon A?

"Place one finger at the corner of your eye near the nose and apply gentle pressure. This will prevent the medication from draining out. Try not to blink or rub your eye.

This medication is to be used in the affected eye(s) up to four times a day, as needed or as directed by your doctor. To use, tilt your head back and look upward, then pull down the lower eyelid to make a pouch. Hold the dropper directly over the eye and place one drop into the pouch. Look downward and gently close your eyes for one to two minutes. Place one finger at the corner of your eye near the nose and apply gentle pressure. This will prevent the medication from draining out. Try not to blink or rub your eye."

Answered by AI

Clinical Trials for Vasocon

Image of QHSLab in West Palm Beach, United States.

Digital Tools for Allergic Rhinitis

18 - 65
All Sexes
West Palm Beach, FL

This study aims to evaluate the effectiveness of digital tools in managing allergic rhinitis (AR) in primary care settings. AR is a common condition that affects many people's quality of life. The study will test whether digital tools, such as the QHSLab platform, can help patients better control their symptoms, improve adherence to treatment, and enhance overall well-being. The trial will compare two groups: one using standard care and the other using both standard care and digital tools. Participants will be monitored over 12 months, and the study will measure changes in symptom severity, treatment adherence, quality of life, and healthcare usage. The study will also gather feedback from patients and healthcare providers about their experience with the digital tools. The digital tools used in this study are designed to help patients manage their AR more effectively by providing regular symptom assessments, medication reminders, and personalized feedback based on their health data. This summary ensures the information is clear and straightforward for patients, families, and healthcare providers while maintaining compliance with IRB guidelines.

Waitlist Available
Has No Placebo

QHSLab

QHSLab, Inc.

Have you considered Vasocon clinical trials?

We made a collection of clinical trials featuring Vasocon, we think they might fit your search criteria.
Go to Trials
Image of Vancouver General Hospital in Vancouver, Canada.

In-Clinic Endoscopic Polypectomy for Nasal Polyps

18+
All Sexes
Vancouver, Canada

Chronic rhinosinusitis, also called chronic sinusitis, is a very common life-long disease affecting over 5% of the Canadian population. Its symptoms, including daily facial pain and headache, an inability to breath through the nose and complete smell loss, regularly impair one's ability to work and to enjoy and participate in daily activities. The annual cost of chronic sinusitis to Canada is estimated at $1.3 billion while the government pays an estimated $860 million yearly for chronic sinusitis treatment. Chronic sinusitis with polyps, the most common type of chronic sinusitis, is usually treated with a combination of medications and surgery. Until now, surgical treatment has only been performed in the operating room, at a cost of about $3500 per procedure. But, recent studies have shown that a new procedure, "in-clinic polyp removal", can provide an improvement in patient symptoms to levels equal to those for sinus surgery performed in a hospital operating room. Moreover, in clinic polyp removal has additional advantages including a shorter procedure recovery time, a significantly lower cost to the health care system (about one-tenth the cost or $450), and a shorter wait time for treatment. With the proposed pragmatic trial, the investigators will determine whether the in clinic polyp removal procedure is as good as sinus surgery in the operating room at controlling patient symptoms of chronic sinusitis. The investigators will also determine the cost and health-benefits for a patient, the healthcare system and for society of in clinic polyp removal in comparison to sinus surgery done in a hospital operating room. The investigators will then know if this new treatment, in clinic polyp removal, can replace sinus surgery as the standard of care for these patients.

Recruiting
Has No Placebo

Vancouver General Hospital (+4 Sites)

Shaun Kilty, MD

Medtronic